Trials Annotator

Status: Withdrawn Suspended Terminated

Trial	Updated / Type	Phase	Were Results Reported	Reported Actual Enrollment	(MeSH) Terms	Why Stopped Limitations And Caveats
NCT01208740 Details	2011-05-24 Interventional	4		88	Metformin Infertility PCOS Prognosis for P…	Concerns about safety at the first interim analysis -
NCT00287742 Details	2011-05-24 Interventional	3		33	Risperidone Alzheimer Disea… Delusions Dementia Hallucinations Alzheimer's Dis…	A decision was made to discontinue the study due to a change in the strategic direction of the company. -
NCT00246597 Details	2011-05-19 Interventional	3		37	Epoetin Alfa Breast Neoplasm… Anemia Chemotherapy, A… Hemoglobins Quality of Life	Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those specified in current labeling. -
NCT00306267 Details	2011-05-18 Interventional	2		61	Epoetin Alfa Anemia Cancer Epoetin Alfa	Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies. -
NCT00211120 Details	2011-05-18 Interventional	4	[1 Refs]	1432	Epoetin Alfa Renal Insuffici… Anemia	Stopped by the DSMB due to a trend toward more adverse events in the higher hemoglobin (Hb) arm and <5% chance that the study would show benefit for higher Hb. -
NCT00312871 Details	2011-05-17 Interventional	4		217	Epoetin Alfa Anemia Kidney Failure,… Renal Insuffici… Renal Insuffici… Renal Failure, …	Study was stopped due to restrictions in labeling for the subcutaneous route of administration of EPREX. -
NCT00236327 Details	2011-05-17 Interventional	4		34	Fentanyl Cancer Pain Pain	Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable. -
NCT00076726 Details	2011-05-17 Interventional	2	[1 Refs]	44	Infliximab Arteritis Giant Cell Arte… Polymyalgia Rhe…	Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage -
NCT00073372 Details	2011-05-17 Interventional	3	[1 Refs]	808	Abciximab Acute Disease Brain Ischemia Ischemic Stroke Stroke Cerebrovascular…	Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume. -
NCT00796900 Details	2011-05-12 Interventional	2/3		-	Dantrolene Fever Hemorrhage Hyperthermia	organizationally not possible -
NCT00470340 Details	2011-05-05 Interventional	3		263	Ethiodized Oil Gemcitabine Oxaliplatin Carcinoma Carcinoma, Hepa… Fibrosis Liver Cirrhosis Liver Neoplasms Neoplasm Recurr… Neoplasms Recurrence	during the study -
NCT00028067 Details	2011-05-04 Interventional	3		-	Atazanavir Sulf… Nelfinavir HIV Infections	- -
NCT00193102 Details	2011-05-03 Interventional	2	[1 Refs]	-	Capecitabine Thalidomide Breast Neoplasm… Breast Cancer	- -
NCT00193024 Details	2011-05-03 Interventional	2	[1 Refs]	-	Docetaxel Epirubicin Breast Neoplasm… Breast Cancer	- -
NCT00216216 Details	2011-05-02 Interventional	2	[1 Refs]	43	Pemetrexed Lung Neoplasms Small Cell Lung… Small Cell Lung…	The results from the interim analysis were not favorable to continue this trial. -
NCT00216138 Details	2011-05-02 Interventional	2		19	Capecitabine Docetaxel Carcinoma, Squa… Head and Neck N… Head and Neck C…	Interim analysis results did not meet criteria for second stage of trial -
NCT00938353 2009-014376-22 Details	2011-04-29 Interventional	3		6	Beclomethasone Croup Laryngitis	possibility to discriminate the active drug from placebo -
NCT00308594 Details	2011-04-28 Interventional	2		-	Dexamethasone Radiculopathy Cervical Radicu…	Study terminated due to withdrawl of participating co-investigators. -
NCT00083486 Details	2011-04-27 Interventional	3		-	Epoetin Alfa Anemia	- -
NCT00975663 Details	2011-04-26 Interventional	4		-	Tacrolimus Lung and Heart-…	- -

Filter:

7805 Trials matched filter criteria